Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Removing EU’s Innovative Device Blockage: Expert Panels Due By End Of July After Lengthy Delays

Executive Summary

The speed to market for innovative products in the EU has been hampered because of the time it has taken to set up “expert panels” under the Medical Device Regulation. Will these products now make 26 May 2021 deadline?

You may also be interested in...



European Commission On Track To Appoint Expert Panel Members By End Of July

Until the EU’s MDR expert panels are in place, notified bodies cannot complete conformity assessment of certain high-risk devices. But progress is being made at last.

Manufacturers That Are Nearly MDR-Ready May Lose Their Advantage Unless Audits Can Take Place Virtually

Industry is urgently seeking certainty over EU virtual notified body audits, fearing that companies now at the front of the MDR line might be sent to the back and have to reapply under the existing directives.

Has EU Sorted Expert Panels As Tsunami Of 700 Applications Pour In After Extended Deadline?

Only just over a month ago there were fears that the implementation of the EU Medical Device Regulation was going to be hampered by a lack of expert panel applicants. Now it seems there is no shortage. The news raises lots of questions about when and how the structure will now work.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142188

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel